| Name | CCR1 antagonist 8 |
|---|
| Description | CCR1 antagonist 8 (compound 19n), a third azaindazole series compound, is a CCR1 antagonist clinical candidate, with an IC50 of 1.8 nM in Ca2+ flux assay[1]. |
|---|---|
| Related Catalog | |
| Target |
CCR1:1.8 nM (IC50, in Ca2+ flux assay) |
| References |
| Molecular Formula | C22H18FN5O3S |
|---|---|
| Molecular Weight | 451.47 |